pubmed-article:21298822 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21298822 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
pubmed-article:21298822 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
pubmed-article:21298822 | lifeskim:mentions | umls-concept:C0019638 | lld:lifeskim |
pubmed-article:21298822 | lifeskim:mentions | umls-concept:C0030580 | lld:lifeskim |
pubmed-article:21298822 | lifeskim:mentions | umls-concept:C1514474 | lld:lifeskim |
pubmed-article:21298822 | lifeskim:mentions | umls-concept:C0441800 | lld:lifeskim |
pubmed-article:21298822 | lifeskim:mentions | umls-concept:C1514983 | lld:lifeskim |
pubmed-article:21298822 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
pubmed-article:21298822 | lifeskim:mentions | umls-concept:C2348519 | lld:lifeskim |
pubmed-article:21298822 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:21298822 | pubmed:dateCreated | 2011-2-4 | lld:pubmed |
pubmed-article:21298822 | pubmed:abstractText | The aim of this study, using a retrospective chart review as the primary study design, was to determine the relative contribution of clinicopathologic risk factors versus low- and high-risk grade histologic groups to assist management of primary parotid cancers. | lld:pubmed |
pubmed-article:21298822 | pubmed:language | eng | lld:pubmed |
pubmed-article:21298822 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21298822 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21298822 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21298822 | pubmed:month | Feb | lld:pubmed |
pubmed-article:21298822 | pubmed:issn | 1097-0347 | lld:pubmed |
pubmed-article:21298822 | pubmed:author | pubmed-author:GoodingWillia... | lld:pubmed |
pubmed-article:21298822 | pubmed:author | pubmed-author:JohnsonJonas... | lld:pubmed |
pubmed-article:21298822 | pubmed:author | pubmed-author:FerrisRobert... | lld:pubmed |
pubmed-article:21298822 | pubmed:author | pubmed-author:HeronDwight... | lld:pubmed |
pubmed-article:21298822 | pubmed:author | pubmed-author:SeethalaRaja... | lld:pubmed |
pubmed-article:21298822 | pubmed:author | pubmed-author:Andrade... | lld:pubmed |
pubmed-article:21298822 | pubmed:author | pubmed-author:WalvekarRohan... | lld:pubmed |
pubmed-article:21298822 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21298822 | pubmed:volume | 33 | lld:pubmed |
pubmed-article:21298822 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21298822 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21298822 | pubmed:pagination | 225-31 | lld:pubmed |
pubmed-article:21298822 | pubmed:meshHeading | pubmed-meshheading:21298822... | lld:pubmed |
pubmed-article:21298822 | pubmed:meshHeading | pubmed-meshheading:21298822... | lld:pubmed |
pubmed-article:21298822 | pubmed:meshHeading | pubmed-meshheading:21298822... | lld:pubmed |
pubmed-article:21298822 | pubmed:meshHeading | pubmed-meshheading:21298822... | lld:pubmed |
pubmed-article:21298822 | pubmed:meshHeading | pubmed-meshheading:21298822... | lld:pubmed |
pubmed-article:21298822 | pubmed:meshHeading | pubmed-meshheading:21298822... | lld:pubmed |
pubmed-article:21298822 | pubmed:meshHeading | pubmed-meshheading:21298822... | lld:pubmed |
pubmed-article:21298822 | pubmed:meshHeading | pubmed-meshheading:21298822... | lld:pubmed |
pubmed-article:21298822 | pubmed:meshHeading | pubmed-meshheading:21298822... | lld:pubmed |
pubmed-article:21298822 | pubmed:meshHeading | pubmed-meshheading:21298822... | lld:pubmed |
pubmed-article:21298822 | pubmed:meshHeading | pubmed-meshheading:21298822... | lld:pubmed |
pubmed-article:21298822 | pubmed:meshHeading | pubmed-meshheading:21298822... | lld:pubmed |
pubmed-article:21298822 | pubmed:meshHeading | pubmed-meshheading:21298822... | lld:pubmed |
pubmed-article:21298822 | pubmed:meshHeading | pubmed-meshheading:21298822... | lld:pubmed |
pubmed-article:21298822 | pubmed:meshHeading | pubmed-meshheading:21298822... | lld:pubmed |
pubmed-article:21298822 | pubmed:meshHeading | pubmed-meshheading:21298822... | lld:pubmed |
pubmed-article:21298822 | pubmed:meshHeading | pubmed-meshheading:21298822... | lld:pubmed |
pubmed-article:21298822 | pubmed:meshHeading | pubmed-meshheading:21298822... | lld:pubmed |
pubmed-article:21298822 | pubmed:meshHeading | pubmed-meshheading:21298822... | lld:pubmed |
pubmed-article:21298822 | pubmed:meshHeading | pubmed-meshheading:21298822... | lld:pubmed |
pubmed-article:21298822 | pubmed:meshHeading | pubmed-meshheading:21298822... | lld:pubmed |
pubmed-article:21298822 | pubmed:meshHeading | pubmed-meshheading:21298822... | lld:pubmed |
pubmed-article:21298822 | pubmed:meshHeading | pubmed-meshheading:21298822... | lld:pubmed |
pubmed-article:21298822 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21298822 | pubmed:articleTitle | Clinicopathologic features as stronger prognostic factors than histology or grade in risk stratification of primary parotid malignancies. | lld:pubmed |
pubmed-article:21298822 | pubmed:affiliation | Department of Otolaryngology, University of Pittsburgh School of Medicine and Cancer Institute, Pittsburgh, Pennsylvania, USA. | lld:pubmed |
pubmed-article:21298822 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21298822 | pubmed:publicationType | Comparative Study | lld:pubmed |